Drug Profile
Ciliary neurotrophic factor
Latest Information Update: 09 Sep 1997
Price :
$50
*
At a glance
- Originator Fidia Farmaceutici; Roche Palo Alto LLC
- Developer Roche Palo Alto LLC
- Class Eye disorder therapies; Obesity therapies
- Mechanism of Action Ciliary neurotrophic factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis